These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 3342395)
1. High-frequency generation of altered Mr 70,000 env glycoproteins in N-methyl-N'-nitro-N-nitrosoguanidine-treated murine tumor cells. Altevogt P; Apt D Cancer Res; 1988 Mar; 48(5):1137-42. PubMed ID: 3342395 [TBL] [Abstract][Full Text] [Related]
2. Endogenous retroviral env genes after N-methyl-N'-nitro-N-nitrosoguanidine treatment of mouse tumor cells: stable DNA amplification and rearrangement. Apt D; Schreck J; Altevogt P Cancer Res; 1989 Jul; 49(14):3966-71. PubMed ID: 2736535 [TBL] [Abstract][Full Text] [Related]
3. Effects of mutagens on the immunogenicity of murine tumor cells: immunological and biochemical evidence for altered cell surface antigens. Altevogt P; von Hoegen P; Leidig S; Schirrmacher V Cancer Res; 1985 Sep; 45(9):4270-7. PubMed ID: 4028013 [TBL] [Abstract][Full Text] [Related]
4. Effects of mutagens on the immunogenicity of tumor cells: comparison of cell surface changes induced by 5-azacytidine and N-methyl-N'-nitro-N-nitrosoguanidine. Altevogt P Cancer Res; 1986 Jun; 46(6):2912-6. PubMed ID: 2421887 [TBL] [Abstract][Full Text] [Related]
5. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors. Manjunath R; Graziano RF; Green WR J Immunol; 1986 Mar; 136(6):2271-9. PubMed ID: 3005407 [TBL] [Abstract][Full Text] [Related]
6. Increase in H-2 antigen expression and immunogenicity of BL6 melanoma cells treated with N-methyl-N'-nitronitrosoguanidine. Gorelik E; Peppoloni S; Overton R; Herberman RB Cancer Res; 1985 Nov; 45(11 Pt 1):5341-7. PubMed ID: 2413992 [TBL] [Abstract][Full Text] [Related]
7. Multiple point mutations in an endogenous retroviral gene confer high immunogenicity on a drug-treated murine tumor. Grohmann U; Puccetti P; Belladonna ML; Fallarino F; Bianchi R; Binaglia L; Sagakuchi K; Mage MG; Appella E; Fioretti MC J Immunol; 1995 May; 154(9):4630-41. PubMed ID: 7722315 [TBL] [Abstract][Full Text] [Related]
8. Identification and immunogenic properties of an 80-kDa surface antigen on a drug-treated tumor variant: relationship to MuLV gp70. Grohmann U; Ullrich SJ; Mage MG; Appella E; Fioretti MC; Puccetti P; Romani L Eur J Immunol; 1990 Mar; 20(3):629-36. PubMed ID: 2318253 [TBL] [Abstract][Full Text] [Related]
9. The cytotoxic T-lymphocyte response against a poorly immunogenic mammary adenocarcinoma is focused on a single immunodominant class I epitope derived from the gp70 Env product of an endogenous retrovirus. Rosato A; Dalla Santa S; Zoso A; Giacomelli S; Milan G; Macino B; Tosello V; Dellabona P; Lollini PL; De Giovanni C; Zanovello P Cancer Res; 2003 May; 63(9):2158-63. PubMed ID: 12727834 [TBL] [Abstract][Full Text] [Related]
10. Altered expression of zinc finger proteins, ADAMs, and integrin-related proteins following treatment of cultured human cells with a low concentration of N-methyl-N'-nitro-N-nitrosoguanidine. Jin J; Gao Z; Guo L; Yang J; Yu Y Environ Mol Mutagen; 2003; 41(5):344-52. PubMed ID: 12802805 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of melanoma-associated antigen expression and ecotropic retrovirus production in B16BL6 melanoma cells transfected with major histocompatibility complex class I genes. Li M; Muller J; Xu F; Hearing VJ; Gorelik E Cancer Res; 1996 Oct; 56(19):4464-74. PubMed ID: 8813142 [TBL] [Abstract][Full Text] [Related]
13. Characterization of variant neuroblastoma clones with missing or altered sodium channels. Costa MR; Catterall WA Mol Pharmacol; 1982 Jul; 22(1):196-203. PubMed ID: 6289070 [TBL] [Abstract][Full Text] [Related]
14. Differential nuclear proteomes in response to N-methyl-N'-nitro-N-nitrosoguanidine exposure. Shen J; Zhu H; Xiang X; Yu Y J Proteome Res; 2009 Jun; 8(6):2863-72. PubMed ID: 19364130 [TBL] [Abstract][Full Text] [Related]
15. Multiple antigens related to the major envelope glycoprotein of murine leukemia virus expressed on B16 melanoma cells as targets of host immune response. Stackpole CW; Demsey A Invasion Metastasis; 1984; 4(1):28-46. PubMed ID: 6329988 [TBL] [Abstract][Full Text] [Related]
16. Kinetics of induction of DNA damage and lacZ gene mutations in stomach mucosa of mice treated with beta-propiolactone and N-methyl-N'-nitro-N-nitrosoguanidine, using single-cell gel electrophoresis and MutaMouse models. Brault D; Renault D; Tombolan F; Thybaud V Environ Mol Mutagen; 1999; 34(2-3):182-9. PubMed ID: 10529742 [TBL] [Abstract][Full Text] [Related]
17. Strand- and sequence-specific attenuation of N-methyl-N'-nitro-N-nitrosoguanidine-induced G.C to A.T transitions by expression of human 6-methylguanine-DNA methyltransferase in Chinese hamster ovary cells. Yang JL; Hsieh FP; Lee PC; Tseng HJ Cancer Res; 1994 Jul; 54(14):3857-63. PubMed ID: 8033107 [TBL] [Abstract][Full Text] [Related]
18. Involvement of dendritic cell response to resistance of stomach carcinogenesis caused by N-methyl-N'-nitro-N-nitrosoguanidine in rats. Oka M; Furihata C; Kitoh K; Yamamoto M; Tatematsu M; Ichinose M; Miki K; Ito T; Sakaki Y; Reske K Cancer Res; 1998 Sep; 58(18):4107-12. PubMed ID: 9751620 [TBL] [Abstract][Full Text] [Related]
19. Differential proliferative response of gastric mucosa during carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in susceptible ACI rats, resistant Buffalo rats, and their hybrid F1 cross. Ohgaki H; Tomihari M; Sato S; Kleihues P; Sugimura T Cancer Res; 1988 Sep; 48(18):5275-9. PubMed ID: 3409251 [TBL] [Abstract][Full Text] [Related]
20. Identification of early responsive genes in human amnion epithelial FL cells induced by N-methyl-N'-nitro-N-nitrosoguanidine using oligonucleotide microarray and quantitative real-time RT-PCR approaches. Li H; Shao J; Lu X; Gao Z; Yu Y Mutat Res; 2008 Sep; 644(1-2):1-10. PubMed ID: 18644392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]